Screener
Eligibility screening
Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
16 US sites in CA, FL, IL, NC +7
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.